TEVA Pharmaceutial Industry ( NASDAQ:TEVA ) to acquire Cephalon for $81.50 per share !

TEVA Pharmaceuticals Industries
Teva Pharmaceutical Industries plans to acquire specialty drug maker Cephalon for $81.50 a share, topping an unsolicited bid by Canada's Valeant Pharmaceuticals International .

Teva (NASDAQ:TEVA) said the deal was worth about $6.8 billion on an enterprise basis.

The deal is worth about $6.2 billion, based on the number of Cephalon shares outstanding, according to Thomson Reuters data.

Stock of Cephalon is up more than 5 % to close to $ 81 in pre market trading while, stock of the TEVA pharmaceuticals is up more than 4% to $47.67 in pre market trade.

( Source: Thomson Reuters)
Tags: , ,

About author

Make it happen !!


Leave a Reply

Related Posts Plugin for WordPress, Blogger...